BETARI, NIBAL
 Distribuzione geografica
Continente #
EU - Europa 54
NA - Nord America 21
AS - Asia 7
Totale 82
Nazione #
IT - Italia 35
US - Stati Uniti d'America 20
FR - Francia 6
CN - Cina 4
SE - Svezia 4
BG - Bulgaria 3
IE - Irlanda 2
IN - India 2
CA - Canada 1
CZ - Repubblica Ceca 1
DE - Germania 1
GB - Regno Unito 1
IR - Iran 1
SI - Slovenia 1
Totale 82
Città #
Bologna 20
Ashburn 6
Forlì 5
Stockholm 4
Cesena 3
Sofia 3
Chiampo 2
Chicago 2
Dublin 2
Kaithal 2
San Diego 2
Buffalo 1
Camerano 1
Guangzhou 1
Houston 1
Krizevci pri Ljutomeru 1
Madison 1
Nanjing 1
New York 1
Paris 1
Prague 1
Seattle 1
Southend 1
Wuxi 1
Totale 64
Nome #
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease., file e1dcb339-c6f1-7715-e053-1705fe0a6cc9 43
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer, file e784e1b4-0dc4-40aa-8e62-ce44660781ad 19
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease., file e1dcb333-c723-7715-e053-1705fe0a6cc9 11
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino)ethyl)amino)indolo[2,1-b]quinazoline-6,12-dione as an antiproliferative agent and to treat cancer, file e1dcb336-9140-7715-e053-1705fe0a6cc9 5
null, file e1dcb32f-4b4d-7715-e053-1705fe0a6cc9 3
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease., file e1dcb338-1723-7715-e053-1705fe0a6cc9 2
Totale 83
Categoria #
all - tutte 315
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 315


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 1 0 0 0 0
2020/20215 0 0 0 1 0 0 0 4 0 0 0 0
2021/202225 0 0 0 0 2 3 2 2 12 1 3 0
2022/202321 4 0 0 1 1 2 3 0 2 1 7 0
2023/202431 3 0 1 6 5 6 5 4 1 0 0 0
Totale 83